Mesoblast【MESO】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

17.20

買値

17.20

売値

17.40

出来高

863,381

12.20 日の範囲 13.7368

0.00 52 週間の範囲 0.00

時価総額

1.964B

前日終値

12.51

始値

13.10

時刻

500

17.2

(formt)

最終取引時間

財務取引量

US$ 11,264,984

VWAP

13.0475

平均取引量 (3 か月)

発行済株式数

114,178,411

配当利回り

PER

-3.66

1 株当たり利益 (EPS)

-0.77

歳入

9.25M

純利益

-87.96M

Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-... Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others. 詳細を表示

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.mesoblast.com

本社

Melbourne, Victoria, Aus

設立

Mesoblast Limited is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker MESO. The last closing price for Mesoblast was US$12.51. Over the last year, Mesoblast shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Mesoblast currently has 114,178,411 shares in issue. The market capitalisation of Mesoblast is US$1.43 billion. Mesoblast has a price to earnings ratio (PE ratio) of -3.66.

全体の流れ

ブルリッシュ

ネットプレミアム

153k

Calls / Puts

100.00%

買い / 売り

100.00%

OTM / ITM

33.33%

Sweeps比率

0.00%

Mesoblast’s RYONCIL® is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy

RYONCIL (remestemcel-L) is the first MSC product approved by FDA for any indication.RYONCIL is the first FDA-approved therapy for children aged 2 months and older, including adolescents and...

Mesoblast to be Added to Nasdaq Biotechnology Index

NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its upcoming...

Form F-3 - Registration statement by foreign private issuers

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease

NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the United States...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

MESO - Frequently Asked Questions (FAQ)

What is the current Mesoblast share price?

The current share price of Mesoblast is US$ 17.20

How many Mesoblast shares are in issue?

Mesoblast has 114,178,411 shares in issue

What is the market cap of Mesoblast?

The market capitalisation of Mesoblast is USD 1.43B

What is the 1 year trading range for Mesoblast share price?

Mesoblast has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Mesoblast?

The price to earnings ratio of Mesoblast is -3.66

What is the cash to sales ratio of Mesoblast?

The cash to sales ratio of Mesoblast is 34.81

What is the reporting currency for Mesoblast?

Mesoblast reports financial results in USD

What is the latest annual turnover for Mesoblast?

The latest annual turnover of Mesoblast is USD 9.25M

What is the latest annual profit for Mesoblast?

The latest annual profit of Mesoblast is USD -87.96M

What is the registered address of Mesoblast?

The registered address for Mesoblast is LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, 3000

What is the Mesoblast website address?

The website address for Mesoblast is www.mesoblast.com

Which industry sector does Mesoblast operate in?

Mesoblast operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
LITMSnow Lake Resources Ltd	US$ 0.7943 (334.04%)	1.2B
NUKKNukkleus Inc	US$ 50.68 (326.60%)	54.52M
PLRZPolyrizon Ltd	US$ 3.256 (210.10%)	137.32M
QMCOQuantum Corporation	US$ 60.085 (153.31%)	22.66M
VRARGlimpse Group Inc	US$ 3.1885 (100.53%)	55.04M
XCHXCHG Ltd	US$ 2.16 (-90.74%)	11.2M
FTELFitell Corporation	US$ 5.50 (-85.67%)	1.69M
XHGXChange TED Inc	US$ 0.754 (-52.28%)	549.39k
MHUAMeihua International Medical Technologies Company Ltd	US$ 0.2755 (-43.82%)	8.86M
RNAZTransCode Therapeutics Inc	US$ 3.915 (-38.00%)	860.08k
LITMSnow Lake Resources Ltd	US$ 0.7943 (334.04%)	1.19B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.3671 (9.94%)	312.75M
CGTXCognition Therapeutics Inc	US$ 0.58295 (28.15%)	284.82M
RGTIRigetti Computing Inc	US$ 10.684 (-4.01%)	276.65M
NVDANVIDIA Corporation	US$ 128.91 (-1.14%)	273.75M